Medications used for medical weight loss have changed the conversation around obesity and metabolic health. Drugs like Ozempic and Wegovy have helped many people lose significant weight, improve blood sugar control, and feel hopeful after years of frustration. But a question that is coming up more and more often in exam rooms and online searches…
By Oregon Weight Loss Surgery From https://barination.com/blogs/barination-blog/ep-267-vitamin-b1-it-s-for-your-brain-the-importance-of-supplementation-when-having-bariatric-surgery-or-starting-glp1-s-with-dr-emma-patterson At Oregon Weight Loss Surgery we believe that education is one of the most powerful tools a patient can have. The more you understand about your body, your surgery, and the changes that take place afterward, the more confident and successful you will be on your weight loss…
Authored By: Oregon Weight Loss Surgery, based on a paper written by Dr. Emma Patterson At Oregon Weight Loss Surgery, our priority is helping patients achieve lasting weight loss. One area of concern that often goes overlooked is thiamine deficiency and its potentially serious neurological consequences, specifically Wernicke’s encephalopathy (WE) and Wernicke-Korsakoff syndrome (WKS). These…
At Oregon Weight Loss Surgery, we understand that weight management is a challenging journey, and medications like GLP-1 (glucagon-like peptide-1 receptor agonists) may seem like a quick fix. While these medications can offer short-term weight loss, it’s important to recognize what happens when you stop taking them. Discontinuation can lead to frustrating and often discouraging…
Obesity treatment has entered an exciting era with two powerful options: GLP‑1 receptor agonist medications (such as semaglutide and tirzepatide) and bariatric surgery (including sleeve gastrectomy and gastric bypass). But while clinical trials often promise dramatic results, how do these approaches perform in day‑to‑day medical practice? Two recent studies—one reported by Reuters at the American…
In recent years, weight loss injections like semaglutide have surged in popularity. These medications promise significant weight loss without the need for surgery, making them a tempting option for individuals struggling with obesity. However, as with any quick fix, there are important factors to consider—side effects, long-term efficacy, and a looming shift in insurance coverage….
Jakob Emerson Original story: The ‘old – fashioned’ weight loss method being embraced by insurers As insurers continue to face major financial pressures related to covering weight loss drugs, many are steering more patients toward bariatric surgery to achieve similar results. “Insurance companies are seeing that they’re getting more reliable outcomes and savings in the…
Presented by Emma Patterson of Oregon Weight Loss Surgery at the 2024 ASMBS Conference Emma J. Patterson, MD, FACS, FRCSC, FASMBS, a renowned expert in bariatric surgery, recently delivered an insightful lecture on “Sleeves in ASC: How I Do It and Clinical Protocols” at the 40th Annual ASMBS Conference in San Diego. The presentation provided…
Rylee Wilson – Wednesday, June 12th, 2024 Blue Cross Blue Shield of Michigan will no longer cover GLP-1 drugs to treat obesity beginning in January, Bloomberg reported June 12. A spokesperson for Michigan’s largest insurer told the news outlet it will drop coverage of GLP-1 drugs for weight loss in fully insured, large group commercial…
In the ever-evolving landscape of obesity management, patients and healthcare professionals alike are presented with an array of choices. One notable trend in recent years has been the comparison between weight loss surgery, medications, and the use of less invasive endoscopic therapy such as intragastric balloons. In this blog, we’ll delve into the effectiveness of…